Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells
Castlemanâs disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a...
Gespeichert in:
Veröffentlicht in: | Clinical nephrology 2014-06, Vol.81 (6), p.445-450 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 450 |
---|---|
container_issue | 6 |
container_start_page | 445 |
container_title | Clinical nephrology |
container_volume | 81 |
creator | Wakabayashi, Keiichi Asanuma, Katsuhiko Takeda, Yukihiko Arakawa, Atsushi Osawa, Isao Horikoshi, Satoshi Yao, Takashi Tomino, Yasuhiko |
description | Castlemanâs disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a variety of systemic complications, although renal complications are uncommon. We present here a case of HV type, unicentric CD with a variety of systemic and renal complications, including the proliferation of glomerular endothelial cells. Various cytokines are thought to be involved in the etiology of this disease, especially interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), which are the main cytokines inducing systemic complications. It has been reported that most PC types and/or multicentric types of CD show increasing levels of serum IL-6 and VEGF, as well as systemic symptoms. Although the current case showed high serum IL-6 and VEGF levels as well as systemic symptoms, the pathological and clinical type were of the HV type and unicentric type, respectively. After immunosuppressive therapy, the serum levels of IL-6 and VEGF returned to the normal range, and systemic complications, including renal involvement, also improved. We report the possibility of pathogenesis via the serum and the pathology of this rare case. |
doi_str_mv | 10.5414/CN107705 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1545189808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1545189808</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-6174baa3b3a838c01e86889b0e400d1623ec2cc7552b50970e97b62660eefacf3</originalsourceid><addsrcrecordid>eNo1kMtOwzAURL0A0VKQ-ALkHWwC13aeSxQBRapgA-voxrmhrhwnxA6of0_KYzWbmaOjYexCwE0Si_i2fBaQZZAcsSUoEBHEChbs1PsdgIRc5SdsIZUUQqliyXbrPVrjiH-i15PFkYf9QLxv-eSMJhdGo3mJPljq0F153hhP6Il_mbDlw9hb09KIwfTuMHq3fUfjD4dc04ctWYOWa7LWn7HjFq2n879csbeH-9dyHW1eHp_Ku000zFIhSkUW14iqVjjLahCUp3le1EAxQCNSqUhLrbMkkXUCRQZUZHUq0xSIWtStWrHrX-5s9zGRD1Vn_MEAHfWTr0QSJyIv8vmLFbv8q051R001jKbDcV_9_6O-AW2VZXw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1545189808</pqid></control><display><type>article</type><title>Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Wakabayashi, Keiichi ; Asanuma, Katsuhiko ; Takeda, Yukihiko ; Arakawa, Atsushi ; Osawa, Isao ; Horikoshi, Satoshi ; Yao, Takashi ; Tomino, Yasuhiko</creator><creatorcontrib>Wakabayashi, Keiichi ; Asanuma, Katsuhiko ; Takeda, Yukihiko ; Arakawa, Atsushi ; Osawa, Isao ; Horikoshi, Satoshi ; Yao, Takashi ; Tomino, Yasuhiko</creatorcontrib><description>Castlemanâs disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a variety of systemic complications, although renal complications are uncommon. We present here a case of HV type, unicentric CD with a variety of systemic and renal complications, including the proliferation of glomerular endothelial cells. Various cytokines are thought to be involved in the etiology of this disease, especially interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), which are the main cytokines inducing systemic complications. It has been reported that most PC types and/or multicentric types of CD show increasing levels of serum IL-6 and VEGF, as well as systemic symptoms. Although the current case showed high serum IL-6 and VEGF levels as well as systemic symptoms, the pathological and clinical type were of the HV type and unicentric type, respectively. After immunosuppressive therapy, the serum levels of IL-6 and VEGF returned to the normal range, and systemic complications, including renal involvement, also improved. We report the possibility of pathogenesis via the serum and the pathology of this rare case.</description><identifier>ISSN: 0301-0430</identifier><identifier>DOI: 10.5414/CN107705</identifier><identifier>PMID: 23211339</identifier><language>eng</language><publisher>Germany</publisher><subject>Aged ; Biomarkers - blood ; Biopsy ; Castleman Disease - blood ; Castleman Disease - drug therapy ; Castleman Disease - pathology ; Cell Proliferation - drug effects ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelial Cells - pathology ; Female ; Humans ; Immunohistochemistry ; Immunosuppressive Agents - therapeutic use ; Interleukin-6 - blood ; Kidney Glomerulus - drug effects ; Kidney Glomerulus - metabolism ; Kidney Glomerulus - pathology ; Treatment Outcome ; Vascular Endothelial Growth Factor A - blood</subject><ispartof>Clinical nephrology, 2014-06, Vol.81 (6), p.445-450</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23211339$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wakabayashi, Keiichi</creatorcontrib><creatorcontrib>Asanuma, Katsuhiko</creatorcontrib><creatorcontrib>Takeda, Yukihiko</creatorcontrib><creatorcontrib>Arakawa, Atsushi</creatorcontrib><creatorcontrib>Osawa, Isao</creatorcontrib><creatorcontrib>Horikoshi, Satoshi</creatorcontrib><creatorcontrib>Yao, Takashi</creatorcontrib><creatorcontrib>Tomino, Yasuhiko</creatorcontrib><title>Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells</title><title>Clinical nephrology</title><addtitle>Clin Nephrol</addtitle><description>Castlemanâs disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a variety of systemic complications, although renal complications are uncommon. We present here a case of HV type, unicentric CD with a variety of systemic and renal complications, including the proliferation of glomerular endothelial cells. Various cytokines are thought to be involved in the etiology of this disease, especially interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), which are the main cytokines inducing systemic complications. It has been reported that most PC types and/or multicentric types of CD show increasing levels of serum IL-6 and VEGF, as well as systemic symptoms. Although the current case showed high serum IL-6 and VEGF levels as well as systemic symptoms, the pathological and clinical type were of the HV type and unicentric type, respectively. After immunosuppressive therapy, the serum levels of IL-6 and VEGF returned to the normal range, and systemic complications, including renal involvement, also improved. We report the possibility of pathogenesis via the serum and the pathology of this rare case.</description><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>Castleman Disease - blood</subject><subject>Castleman Disease - drug therapy</subject><subject>Castleman Disease - pathology</subject><subject>Cell Proliferation - drug effects</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelial Cells - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Interleukin-6 - blood</subject><subject>Kidney Glomerulus - drug effects</subject><subject>Kidney Glomerulus - metabolism</subject><subject>Kidney Glomerulus - pathology</subject><subject>Treatment Outcome</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><issn>0301-0430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMtOwzAURL0A0VKQ-ALkHWwC13aeSxQBRapgA-voxrmhrhwnxA6of0_KYzWbmaOjYexCwE0Si_i2fBaQZZAcsSUoEBHEChbs1PsdgIRc5SdsIZUUQqliyXbrPVrjiH-i15PFkYf9QLxv-eSMJhdGo3mJPljq0F153hhP6Il_mbDlw9hb09KIwfTuMHq3fUfjD4dc04ctWYOWa7LWn7HjFq2n879csbeH-9dyHW1eHp_Ku000zFIhSkUW14iqVjjLahCUp3le1EAxQCNSqUhLrbMkkXUCRQZUZHUq0xSIWtStWrHrX-5s9zGRD1Vn_MEAHfWTr0QSJyIv8vmLFbv8q051R001jKbDcV_9_6O-AW2VZXw</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Wakabayashi, Keiichi</creator><creator>Asanuma, Katsuhiko</creator><creator>Takeda, Yukihiko</creator><creator>Arakawa, Atsushi</creator><creator>Osawa, Isao</creator><creator>Horikoshi, Satoshi</creator><creator>Yao, Takashi</creator><creator>Tomino, Yasuhiko</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20140601</creationdate><title>Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells</title><author>Wakabayashi, Keiichi ; Asanuma, Katsuhiko ; Takeda, Yukihiko ; Arakawa, Atsushi ; Osawa, Isao ; Horikoshi, Satoshi ; Yao, Takashi ; Tomino, Yasuhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-6174baa3b3a838c01e86889b0e400d1623ec2cc7552b50970e97b62660eefacf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>Castleman Disease - blood</topic><topic>Castleman Disease - drug therapy</topic><topic>Castleman Disease - pathology</topic><topic>Cell Proliferation - drug effects</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelial Cells - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Interleukin-6 - blood</topic><topic>Kidney Glomerulus - drug effects</topic><topic>Kidney Glomerulus - metabolism</topic><topic>Kidney Glomerulus - pathology</topic><topic>Treatment Outcome</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wakabayashi, Keiichi</creatorcontrib><creatorcontrib>Asanuma, Katsuhiko</creatorcontrib><creatorcontrib>Takeda, Yukihiko</creatorcontrib><creatorcontrib>Arakawa, Atsushi</creatorcontrib><creatorcontrib>Osawa, Isao</creatorcontrib><creatorcontrib>Horikoshi, Satoshi</creatorcontrib><creatorcontrib>Yao, Takashi</creatorcontrib><creatorcontrib>Tomino, Yasuhiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wakabayashi, Keiichi</au><au>Asanuma, Katsuhiko</au><au>Takeda, Yukihiko</au><au>Arakawa, Atsushi</au><au>Osawa, Isao</au><au>Horikoshi, Satoshi</au><au>Yao, Takashi</au><au>Tomino, Yasuhiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells</atitle><jtitle>Clinical nephrology</jtitle><addtitle>Clin Nephrol</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>81</volume><issue>6</issue><spage>445</spage><epage>450</epage><pages>445-450</pages><issn>0301-0430</issn><abstract>Castlemanâs disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a variety of systemic complications, although renal complications are uncommon. We present here a case of HV type, unicentric CD with a variety of systemic and renal complications, including the proliferation of glomerular endothelial cells. Various cytokines are thought to be involved in the etiology of this disease, especially interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), which are the main cytokines inducing systemic complications. It has been reported that most PC types and/or multicentric types of CD show increasing levels of serum IL-6 and VEGF, as well as systemic symptoms. Although the current case showed high serum IL-6 and VEGF levels as well as systemic symptoms, the pathological and clinical type were of the HV type and unicentric type, respectively. After immunosuppressive therapy, the serum levels of IL-6 and VEGF returned to the normal range, and systemic complications, including renal involvement, also improved. We report the possibility of pathogenesis via the serum and the pathology of this rare case.</abstract><cop>Germany</cop><pmid>23211339</pmid><doi>10.5414/CN107705</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-0430 |
ispartof | Clinical nephrology, 2014-06, Vol.81 (6), p.445-450 |
issn | 0301-0430 |
language | eng |
recordid | cdi_proquest_miscellaneous_1545189808 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Aged Biomarkers - blood Biopsy Castleman Disease - blood Castleman Disease - drug therapy Castleman Disease - pathology Cell Proliferation - drug effects Endothelial Cells - drug effects Endothelial Cells - metabolism Endothelial Cells - pathology Female Humans Immunohistochemistry Immunosuppressive Agents - therapeutic use Interleukin-6 - blood Kidney Glomerulus - drug effects Kidney Glomerulus - metabolism Kidney Glomerulus - pathology Treatment Outcome Vascular Endothelial Growth Factor A - blood |
title | Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T23%3A48%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyaline%20vascular%20type%20of%20unicentric%20Castleman's%20disease%20with%20proliferation%20of%20glomerular%20endothelial%20cells&rft.jtitle=Clinical%20nephrology&rft.au=Wakabayashi,%20Keiichi&rft.date=2014-06-01&rft.volume=81&rft.issue=6&rft.spage=445&rft.epage=450&rft.pages=445-450&rft.issn=0301-0430&rft_id=info:doi/10.5414/CN107705&rft_dat=%3Cproquest_pubme%3E1545189808%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1545189808&rft_id=info:pmid/23211339&rfr_iscdi=true |